ShadowBuys
Sign inJoin for free

Amgen (AMGN)

Healthcare · Drug Manufacturers - General

30 members of Congress have disclosed 98 trades in Amgen (AMGN) since 2014: 55 buys and 43 sales. The most recent was disclosed on Nov 2, 2026. 9 trades were made by members of a committee that oversees Amgen's industry.

Trades disclosed
98
Members trading
30
Buys / sells
55 / 43
Reported value
$809K–$3M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow AMGN

Research connections

Patterns in the available disclosures. Each source has its own timing and reporting limits.

2 congressional households disclosed buys

Disclosures in the past 90 days. These may cover different transaction dates and owners.

What else is happening at AMGN

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. AMGNContract award·USAspending

    AMGN: Department of Health and Human Services contract award

    NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)

    First observed: Nov 8, 2026, 9:57 AM ESTEvent / period: Aug 28, 2023Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. AMGNFinancial report·SEC EDGAR

    AMGN: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 3, 2026, 6:37 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. AMGNCompany announcement·SEC EDGAR

    AMGN: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 4:05 PM ESTEvent / period: Nov 3, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  4. AMGNCompany announcement·SEC EDGAR

    AMGN: Leadership change

    Filed 8-K for an event or period dated 2026-10-26. Leadership change.

    Public: Oct 26, 2026, 5:58 PM EDTEvent / period: Oct 26, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Amgen's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded AMGN

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.